• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
44.20
  -0.08  
- 0.18%
330,752,000
49.83
25.49

Insider Trade Data

Date Insider Shares Type Value
08/26/2014 Pacelli, Steven Robert 30,000 Exchange $437,220
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/26/2014 Pacelli, Steven Robert 30,000 Sell $1,336,861
08/25/2014 Doubleday, Richard B 24,000 Sell $1,077,684
08/25/2014 Doubleday, Richard B 24,000 Exchange $220,120

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!